Literature DB >> 33855310

Maternal to fetal transmission of cancer: implications for molecular tumor testing, immune regulation, and pediatric malignancies.

Ramez N Eskander1, Razelle Kurzrock2.   

Abstract

Molecular tumor testing has transformed the treatment of patients with malignancies and is helping catalyze the development of novel therapeutic strategies. In a recent issue of The New England Journal of Medicine, Arakawa et al. describe two cases of pediatric lung cancer resulting from mother-to-infant transmission, diagnosed remote from delivery.1.

Entities:  

Mesh：

Year:  2021        PMID： 33855310      PMCID： PMC8040028          DOI： 10.1016/j.medj.2021.02.006

Source DB:  PubMed          Journal:  Med (N Y)        ISSN： 2666-6340


  10 in total

1.  Immunologically silent cancer clone transmission from mother to offspring.

Authors:  Takeshi Isoda; Anthony M Ford; Daisuke Tomizawa; Frederik W van Delft; David Gonzalez De Castro; Norkio Mitsuiki; Joannah Score; Tomohiko Taki; Tomohiro Morio; Masatoshi Takagi; Hiroh Saji; Mel Greaves; Shuki Mizutani
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-12       Impact factor: 11.205

2.  Maternal to fetal transmission of cervical carcinoma.

Authors:  Ethel Herskovic; Maura Ryan; Joanna Weinstein; Nitin R Wadhwani
Journal:  Pediatr Radiol       Date:  2014-01-10

3.  Vaginal Transmission of Cancer from Mothers with Cervical Cancer to Infants.

Authors:  Ayumu Arakawa; Hitoshi Ichikawa; Takashi Kubo; Noriko Motoi; Tadashi Kumamoto; Miho Nakajima; Kan Yonemori; Emi Noguchi; Kuniko Sunami; Kouya Shiraishi; Hiroki Kakishima; Hiroshi Yoshida; Tomoro Hishiki; Naonori Kawakubo; Takafumi Kuroda; Takako Kiyokawa; Kyosuke Yamada; Nozomu Yanaihara; Kazuaki Takahashi; Aikou Okamoto; Shinsuke Hirabayashi; Daisuke Hasegawa; Atsushi Manabe; Kentaro Ono; Masaki Matsuoka; Yasuhito Arai; Yosuke Togashi; Tatsuhiro Shibata; Hiroyoshi Nishikawa; Kazunori Aoki; Noboru Yamamoto; Takashi Kohno; Chitose Ogawa
Journal:  N Engl J Med       Date:  2021-01-07       Impact factor: 91.245

4.  Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study.

Authors:  Hyun Cheol Chung; Willeke Ros; Jean-Pierre Delord; Ruth Perets; Antoine Italiano; Ronnie Shapira-Frommer; Lyudmila Manzuk; Sarina A Piha-Paul; Lei Xu; Susan Zeigenfuss; Scott K Pruitt; Alexandra Leary
Journal:  J Clin Oncol       Date:  2019-04-03       Impact factor: 44.544

5.  Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).

Authors:  Krishnansu S Tewari; Michael W Sill; Richard T Penson; Helen Huang; Lois M Ramondetta; Lisa M Landrum; Ana Oaknin; Thomas J Reid; Mario M Leitao; Helen E Michael; Philip J DiSaia; Larry J Copeland; William T Creasman; Frederick B Stehman; Mark F Brady; Robert A Burger; J Tate Thigpen; Michael J Birrer; Steven E Waggoner; David H Moore; Katherine Y Look; Wui-Jin Koh; Bradley J Monk
Journal:  Lancet       Date:  2017-07-27       Impact factor: 79.321

Review 6.  Human papillomavirus infections in children: the potential role of maternal transmission.

Authors:  S Syrjänen; M Puranen
Journal:  Crit Rev Oral Biol Med       Date:  2000

7.  Intracranial metastasis via transplacental (vertical) transmission of maternal small cell lung cancer to fetus: CT and MRI findings.

Authors:  M Teksam; A McKinney; J Short; S O Casey; C L Truwit
Journal:  Acta Radiol       Date:  2004-08       Impact factor: 1.990

8.  Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: A hospital-based study.

Authors:  Kuniko Sunami; Hitoshi Ichikawa; Takashi Kubo; Mamoru Kato; Yutaka Fujiwara; Akihiko Shimomura; Takafumi Koyama; Hiroki Kakishima; Mayuko Kitami; Hiromichi Matsushita; Eisaku Furukawa; Daichi Narushima; Momoko Nagai; Hirokazu Taniguchi; Noriko Motoi; Shigeki Sekine; Akiko Maeshima; Taisuke Mori; Reiko Watanabe; Masayuki Yoshida; Akihiko Yoshida; Hiroshi Yoshida; Kaishi Satomi; Aoi Sukeda; Taiki Hashimoto; Toshio Shimizu; Satoru Iwasa; Kan Yonemori; Ken Kato; Chigusa Morizane; Chitose Ogawa; Noriko Tanabe; Kokichi Sugano; Nobuyoshi Hiraoka; Kenji Tamura; Teruhiko Yoshida; Yasuhiro Fujiwara; Atsushi Ochiai; Noboru Yamamoto; Takashi Kohno
Journal:  Cancer Sci       Date:  2019-04-02       Impact factor: 6.716

9.  A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors.

Authors:  Sandip P Patel; Young Kwang Chae; Megan Othus; Francis J Giles; Donna E Hansel; Preet Paul Singh; Annette Fontaine; Manisha H Shah; Anup Kasi; Tareq Al Baghdadi; Marc Matrana; Zoran Gatalica; W Michael Korn; Jourdain Hayward; Christine McLeod; Helen X Chen; Elad Sharon; Edward Mayerson; Christopher W Ryan; Melissa Plets; Charles D Blanke; Razelle Kurzrock
Journal:  Clin Cancer Res       Date:  2020-01-22       Impact factor: 12.531
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.